Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
0
Like
Facebook
Tweet
Print
Clinical Pharmacology – Chemical
Session: Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)
Perspectives on the MIDD Aspects in Development of New Drugs During the COVID-19 Pandemic
Monday, October 17, 2022
10:00 AM – 10:30 AM
ET
Location: 151 AB
Government Speaker(s)
Eliford Ngaimisi Kitabi, PhD
Pharmacometrics reviewer
FDA
Handouts
None
Learning Objectives:
Define model informed drug development (MIDD)
State different aspects of MIDD
Familiarize with examples of different aspects of MIDD during the covid-19 pandemic
Develop personal opinions on the different aspects of MIDD
